Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...Read more

Mylan signs a settlement agreement with OSI Pharma

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more

India bans pain killer 36 years after the US did so

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...Read more

Beximco Pharma enters EU market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...Read more

Glenmark's new generic gets FDA nod

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2015

Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...Read more

Amneal pharma to acquire Actavis Australia's generic business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...Read more

ANI pharma, IDT Australia to commercialize US generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...Read more

Brickell Biotech-Kaken Pharma to co-develop dermatology drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...Read more

Lupin scouts for acquisitions across the world

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...Read more

US rheumatoid arthritis market to reach $9.3 bn by 2020'

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 02 Apr, 2015

Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...Read more

BioSpectrum announces the hits and misses of 2013

Generics |  Analysis | By BioSpectrum Bureau  | 9 Comment | 02 Jan, 2014

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...Read more

Teva proposes to buy Mylan for $40.1 billion

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about ...Read more

Teva's Potential $40 bn Mylan acquisition could transform generics space'

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 27 Apr, 2015

Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is cruc...Read more

TB claims 74000 children each year: WHO

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...Read more

Boehringer, Lilly diabetes drug shows +ve results

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...Read more

Indian drugmakers shifting R&D to South East Asia

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical in...Read more

Unlike FDA, Indian regulators finds no violations at Ranbaxy

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, i...Read more

Pfizer, Hisun launch generics joint venture in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the la...Read more